Doctor Argyrios Ntalianis

Doctor Argyrios Ntalianis

Alexandra University Hospital, Athens (Greece)

Member of:

Dr Argyrios Ntalianis graduated the medical school of the University of Athens, Greece in 1995. He completed his fellowship in Cardiology and his phD thesis in 2006. From 2007 to 2010 he was subspecialized in Interventional Cardiology in Cardiovascular Center Aalst, Belgium and from 2010-2013 in Heart failure in the 3rd Cardiology Clinic, University of Athens, Greece under the mentorship of professor John Nanas. He worked as a cardiology consultant and interventional cardiology consultant in Saint George's Healthcard NHS Trust, London, UK and in Kingston Hospital NHS Trust, Surrey, UK from 2013 to 2014. Since 2016 dr Ntalianis is working as a Cardiology Consultant in Alexandra Hospital, Department of Clinical Therapeutics, Athens, Greece. He is of the founders of the Heart Failure and Cardio-Oncology Unit as well as the Coronary Artery Disease and Myocardiopathy outpatient Clinic in Alexandra Hospital. In 2022 he was elected president of the Greek Working Group of Heart Failure.

Presentations

Biomarkers and imaging modalities for the diagnosis of cardiotoxicity after chemotherapy; data from the greek multicenter cardio-oncology registry

Event: Heart Failure 2019

Topic: Cardio-Oncology

Session: Cardiovascular Disease in Special Populations

Access

Small tolerated enalapril doses before ARNI administration predicts adverse events during ARNI up-titration

Event: Heart Failure 2019

Topic: Pharmacotherapy

Session: Chronic Heart Failure – Treatment

Access

Hypertrophic cardiomyopathy or light chain cardiac amyloidosis?

Event: Heart Failure 2018

Topic: Hypertrophic Cardiomyopathy

Session: Clinical Case Corner 6 - Such a big, big heart: cases of (pseudo)hypertrophy

Access

Safety and efficacy of valsartan-sacubitril in a cohort of patients with symptomatic heart failure receiving small doses of ACE

Event: Heart Failure 2018

Topic: Treatment

Session: Chronic Heart Failure – Treatment

Access

Doctor Argyrios Ntalianis

Biography

Contributor content

Biomarkers and imaging modalities for the diagnosis of cardiotoxicity after chemotherapy; data from the greek multicenter cardio-oncology registry

Small tolerated enalapril doses before ARNI administration predicts adverse events during ARNI up-titration

Hypertrophic cardiomyopathy or light chain cardiac amyloidosis?

Safety and efficacy of valsartan-sacubitril in a cohort of patients with symptomatic heart failure receiving small doses of ACE

ESC 365 is supported by